MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia

Introduction Multiple myeloma (MM) is a plasma cell tumour with over 5800 new cases each year in the UK. The introduction of biological therapies has improved outcomes for the majority of patients with MM, but in approximately 20% of patients the tumour is characterised by genetic changes which conf...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Andrew Hall, Sarah Brown, Samantha Hinsley, Debbie Sherratt, Louise Flanagan, Sadie Roberts, Katrina Walker, Guy Pratt, Christina Messiou, Matthew Jenner, Martin Kaiser
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 2021-03-01
Edice:	BMJ Open
On-line přístup:	https://bmjopen.bmj.com/content/11/3/e046225.full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!